Navigation Links
ULURU Inc. Hosts Symposium on Altrazeal(TM) at the 23rd Annual Clinical Symposium on Advances in Skin & Wound Care
Date:10/30/2008

- Dr. Jeffrey A. Niezgoda and Dr. Peter J. Sordi provide updates on a wide

range of patient treatment experiences with Altrazeal(TM) -

- John St. John, Ph.D. gives perspectives on design and features of

Altrazeal(TM) -

LAS VEGAS, Oct. 30 /PRNewswire-FirstCall/ -- ULURU Inc. (Amex: ULU) -- Clinical updates and new case studies on the application of Altrazeal(TM) - Transforming Powder Dressing were presented yesterday at a special session of this year's annual Clinical Symposium on Advances in Skin & Wound Care. The session was hosted by ULURU Inc.

Dr. Jeffrey A. Niezgoda, M.D., FACHM, FAPWCA, director of the Centers for Comprehensive Wound Care and Hyperbaric Oxygen Therapy, Aurora Health Care, presented in-depth clinical updates on patients treated with Altrazeal(TM). Cases included venous ulcers, a diabetic foot ulcer, and a chronic wound associated with a mastectomy and radiation therapy. In many cases, patients treated with standard of care who had wounds that had failed to heal for periods up to six months healed and in all cases patients experienced significant improvements in healing and pain reduction after treatment with Altrazeal(TM). Assessing the implications of these case studies to attendees, Dr. Niezgoda stated that "we have tested Altrazeal(TM) in the treatment of more than 50 patients. This product is a significant advance in the care and treatment of wounds and will transform the way we do wound care."

Dr. Peter J. Sordi, M.D., FACS, also presented clinical experience from cases of patients under his care. Dr. Sordi reported that one immediate benefit was the reduction of pain in patients treated with Altrazeal(TM). Cases he presented included trauma, venous
'/>"/>

SOURCE ULURU Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. ULURU Inc. to Present at UBS Global Life Sciences Conference 2007
2. ULURU Inc. Announces Odd-Lot Buy Back Offer
3. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2007 and Provide a Business Update
4. ULURU Inc. Reports Third Quarter 2007 Results
5. ULURU Inc. Announces Issuance of Notice of Allowance for Nanoparticle Aggregate Patent
6. ULURU Inc. to Present at Cowen and Company 28th Annual Health Care Conference 2008
7. ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2008 and Provide a Business Update
8. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter Ended December 31, 2007 and Provide a Business Update
9. ULURU Inc. Announces the Launch Plan for Altrazeal(TM)
10. ULURU Inc. Reports First Quarter 2008 Financial Results
11. ULURU Inc. Announces the Appointment of Ronald A. Ahrens to the Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... in eventual development of screening test, resear...thDay News) -- New research points to the possibil...disease. , People with high blood pressure who ...on in the body were found to be twice as likely as...t failure, the study found. , The finding may l...
(Date:12/3/2009)...ONT, Calif., Dec. 3 The...eleased findings today from one of the largest stu...in women conducted by the Northern California Can...at women who never smoked cigarettes and who were ...ime--especially during adulthood--had a significan...
(Date:12/3/2009)... JOLLA, Calif., Dec. 3 ...iological Studies unanimously voted to elect thre...la. ,, Fred Dotzler is co-founder and Managin.... De Novo is investing $650 million from three fun... companies. Dotzler founded Medicus Venture Partne...
(Date:12/3/2009)...PASADENA, Calif., Dec. 3 For Calif... the risk of disability remains one of the most si...cial well being, but also their business,s viabili...ave taken their toll, owners of small businesses a...l safety net with enhanced disability coverage," s...
(Date:12/3/2009)...RASOTA, Fla., Dec. 3 If you have s...t ready for a stunning look at the other side of t...od will screen her feature documentary, "Superchar...ay, December 8th, 5 p.m. at Sever Hall, Harvard Ya...iving" College Tour. The film will be followed by ...
Breaking Medicine News(10 mins):Health News:Vitamin D May Be Tied to Heart Disease Via Genes 2Health News:Northern California Cancer Center's Findings on Breast Cancer and Secondhand Smoke Released Internationally by the American Association for Cancer Research 2Health News:Salk Institute Board of Trustees Elects Leaders in Venture Capital and Publishing to its Membership 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 3Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 4Health News:Jenna Norwood to Present Award-Winning Documentary & Lecture at Harvard University 2
...inal Health, a global provider of products and ser...health care, today launched nine new products targ...perating rooms, including high-performance surgica...urgical scrubs market , Cardinal Health is enteri...
...Tools, Inc. is happy to announce the birth of Clin...ns developed exclusively to assist healthcare prov...nic Medical Record (EMR) designed to serve as a tr...e providers. , , ClinicTools(R) makes it easier ...
...e the Way People Think About End-of-Life , , Rece...er Ken Burns , , DETROIT, March 17 Hospice of Mi...pice organizations, has produced a documentary fil...- 5:30 pm. For television channels, see the tele...
... now just a phone call away for parents, pediatric...al professionals caring for any child in Ohio with...ess. , , The Comfort Line is a medical advice and... , Toll-free phone calls are accepted Monday throu...
...n syringes are the oldest delivery method availabl...e in Europe. Several factors have contributed to t...tance and popularity of insulin pens. , , (Logo:...n Insulin Delivery Devices Market , finds that the...
...st Listen is a newly launched service that provide...oking to talk, vent or just share what,s on their ...B) March 17, 2009 -- The stock market is in the ta...ut words not everyone may want to hear. Now, peopl...
Other Medicine News:Health News:Cardinal Health Launches New Products for the Operating Room 2Health News:Cardinal Health Launches New Products for the Operating Room 3Health News:Cardinal Health Launches New Products for the Operating Room 4Health News:Cardinal Health Launches New Products for the Operating Room 5Health News:Electronic Medical Record of the Future Is Here 2Health News:Hospice of Michigan Documentary to Air on Detroit Public Television Monday, March 23 and Sunday, March 29 2Health News:'Comfort' Now Available to Caregivers of Ohio's Seriously-Ill Children 2Health News:Insulin Pens and Growing Diabetic Community Increase Market for Insulin Delivery Devices in Europe, Says Frost & Sullivan 2Health News:Insulin Pens and Growing Diabetic Community Increase Market for Insulin Delivery Devices in Europe, Says Frost & Sullivan 3Health News:Insulin Pens and Growing Diabetic Community Increase Market for Insulin Delivery Devices in Europe, Says Frost & Sullivan 4Health News:Confidential Listening Service We Just Listen Launches, Providing Americans a Private Platform to Express Their Thoughts and Feelings 2
(Date:12/3/2009)... HOERSHOLM, Denmark and SAN DIEGO, California, Dec...ssfully Inhibits miR-122, a microRNA Important for...tly Reducing Hepatitis C,Virus in the Bloodstream ...itis C Virus , - SPC3649 Demonstrates Eff...Serious Adverse Events in the Treated Animals - Si...
(Date:12/3/2009)... Dec. 3 Cardium Therapeu...holly-owned subsidiary, Tissue Repair Company, sub... the U.S. Food and Drug Administration (FDA) seeki...duct candidate based on positive data from the Com... study. Today,s submission with the FDA covers Ex...
(Date:12/3/2009)...alif., Dec. 3 Jazz Pharm...that Kathryn E. Falberg has been appointed Senior ...alberg brings to Jazz Pharmaceuticals more than 20...e. As Jazz Pharmaceutical,s CFO, Ms. Falberg will...orate finance, financial planning, investor relati...
Breaking Medicine Technology:New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5Weight Watchers 28R 29 Launches New Community on WeightWatchers com 55510 1Weight Watchers 28R 29 Launches New Community on WeightWatchers com 55510 2Weight Watchers 28R 29 Launches New Community on WeightWatchers com 55510 3Get Ready for Gruesome Cigarette Warnings 55508 1Get Ready for Gruesome Cigarette Warnings 55508 2Get Ready for Gruesome Cigarette Warnings 55508 3Mindray Medical to Participate in the SIG Third Annual Beijing Management Summit 55505 1Mindray Medical to Participate in the SIG Third Annual Beijing Management Summit 55505 2
...Form Medical,Inc. (Nasdaq: BFRM ) today announced...nded comparative study of nasolabial fold treatmen...Radiesse(R) dermal filler,than reported after trea...results of this study were published in the Decemb...c Surgery, a peer-reviewed publication of the,Amer...
...ent in Motor Function at 24 Months, SAN DIEGO, De...llow-up data from a Phase 1 clinical trial of CERE...ase. CERE-120 uses gene therapy to,deliver the neu...eurodegeneration that occurs in the brains of Park...ssments at 18 and 24 months post,treatment, sugges...
Other Medicine Technology:Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 2Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 3Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 4Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 5Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 6Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 2Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 3Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 4
Streck-Kleen Enzymatic Cleanser
Streck-Diluent III Plus Balanced Electrolyte Solution
Streck-CN free Lyse CD Lytic Reagent
...ted red blood cell (nRBC) control for evaluating t... 755 hematology analyzer in its enumeration of the...r LH 750/LH 755. nRBC-Chex for LH is a two-level c...nRBC-Chex for LH has a 75-day closed-vial stabilit...
Medicine Products: